Switzerland · Series B startup
5 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$91Mraised across 5 rounds since 2009, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Ventech
Novartis Venture Fund
Seroba KernelReported by covagen.com
Reported by covagen.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
VentechNovartis Venture FundMP Healthcare Venture ManagementEdmond de Rothschild Venture CapitalBaxter VenturesSeroba Kernel
GimvAscent Biomedical VenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Covagen's investors include Ventech, Novartis Venture Fund, MP Healthcare Venture Management, Edmond de Rothschild Venture Capital and Baxter Ventures, and 3 more on record.
Covagen has raised $91M across 5 rounds since 2009. One round did not disclose an amount, so the total is a floor.
Covagen's most recent round was a Series B of $2.8M in Feb 2014.
Covagen's largest round on record is $47M (Series B), in Dec 2013.
Covagen's first round on record, in Oct 2009, was backed by Novartis Venture Fund and MP Healthcare Venture Management.
Covagen's latest named round is a Series B, in Feb 2014.
Covagen is based in Switzerland.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland ·